ScholarLens Back to search
2020•Autoimmunity ReviewsRequires access

Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis

Dario Roccatello, Roberta Fenoglio, Simone Baldovino, Carla Naretto, Michela Ferro, Antonella Barreca, Daniela Rossi, Savino Sciascia

Open publisher page 2 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 2 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Plasma cell dyscrasia, Dyscrasia, AL amyloidosis, Immunoglobulin light chain, Amyloidosis, Plasma cell, Daratumumab, Monoclonal

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Towards a novel target therapy for renal diseases related to plasma cell dyscrasias: The example of AL amyloidosis — Research Paper | ScholarLens